Show simple item record

Mechanisms of oxidant-induced changes in erythrocytes

dc.contributor.authorHatherill, J. R.en_US
dc.contributor.authorTill, Gerd O.en_US
dc.contributor.authorWard, Peter A.en_US
dc.date.accessioned2006-09-11T15:30:53Z
dc.date.available2006-09-11T15:30:53Z
dc.date.issued1991-03en_US
dc.identifier.citationHatherill, J. R.; Till, G. O.; Ward, P. A.; (1991). "Mechanisms of oxidant-induced changes in erythrocytes." Agents and Actions 32 (3-4): 351-358. <http://hdl.handle.net/2027.42/44974>en_US
dc.identifier.issn0065-4299en_US
dc.identifier.issn1420-908Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44974
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1862753&dopt=citationen_US
dc.description.abstractThere is an increasing body of experimental studies demonstrating the toxic effects of oxygen-derived free radicals. Evidence supports an important role for free radicals in ischemic injuries, inflammation, and chemical-induced tissue injury. Free radicals are involved in normal biochemical processes like oxidative reduction and cellular metabolism; however, they also mediate disease processes. The participation of oxygen free radicals in lysis of red cells is important in some situations of intravascular hemolysis. This article will review neutrophil-derived oxygen free radicals, emphasizing: (1) their effects on the erythrocyte and (2) how these effects may be attenuated.en_US
dc.format.extent646811 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherBirkhäuser-Verlag; Birkhäuser Verlag ; Springer Science+Business Mediaen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherImmunologyen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherAllergologyen_US
dc.subject.otherDermatologyen_US
dc.subject.otherNeurologyen_US
dc.subject.otherRheumatologyen_US
dc.titleMechanisms of oxidant-induced changes in erythrocytesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherRadian Corporation, 2250 E. Imperial Hwy., Suite 140, 90245, El Segundo, CA, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid1862753en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44974/1/11_2005_Article_BF01980898.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF01980898en_US
dc.identifier.sourceAgents and Actionsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.